Bartonella genus (IgM)

Sample type: Serum
Negative
If the Bartonella genus (IgM) test results are negative, it generally suggests that the individual's immune system has not produced IgM antibodies against the Bartonella bacteria, or the levels are too low to be detected. This can imply several possibilities: the person may not have been infected with Bartonella, the infection could be in a very early stage where antibodies have not yet developed, or it might be a past infection where IgM antibodies have already declined to undetectable levels. It's important to note that a negative result does not categorically rule out a Bartonella infection, especially if clinical symptoms suggestive of bartonellosis are present. In such cases, additional testing, possibly including different types of assays or repeat testing at a later time, may be required for a definitive diagnosis.
Indeterminate
Bartonella bacteria are a group of microorganisms known for causing infections in humans and animals, often transmitted through bites or scratches from infected animals like cats, or by insect vectors like fleas and ticks. Common human diseases caused by Bartonella include Cat Scratch Disease, typically resulting from a cat scratch or bite, and Trench Fever, historically associated with soldiers in the trenches of World War I. If the results of a Bartonella genus (IgM) test are "Indeterminate," it means that the test has detected IgM antibodies against Bartonella bacteria, but the levels are not definitive enough to clearly classify the result as either positive or negative. This ambiguous result can be due to several reasons. Firstly, it might indicate that the antibody levels are at a borderline range – possibly because the infection is in a very early stage where the immune response is just beginning to develop, or in a resolving phase where antibody levels are decreasing but still detectable. Secondly, it could be a result of cross-reactivity, where antibodies produced in response to another infection or condition are mistakenly reacting with the Bartonella antigens used in the test. Lastly, technical issues with the test itself, such as problems with the assay reagents or procedure, can sometimes lead to indeterminate results. When an indeterminate result is obtained, it's important to consider other clinical information, including symptoms and potential exposure history. In some cases, additional testing, which may include repeat serology after some time or alternative diagnostic methods like PCR (Polymerase Chain Reaction), might be necessary to clarify the diagnosis. This indeterminate outcome underscores the complexity of diagnosing Bartonella infections and highlights the necessity of integrating laboratory results with clinical evaluation for accurate diagnosis and management.
Positive
A positive result on the Bartonella genus (IgM) test indicates that the individual's immune system has produced IgM antibodies specifically targeting the Bartonella bacteria. This typically suggests a recent or current infection with a Bartonella species, as IgM antibodies are usually produced early in response to an infection and are detectable within a week or two after exposure. The presence of these antibodies, however, should be interpreted in conjunction with clinical symptoms and the patient's medical history, as false positives can occur due to cross-reactivity with other pathogens or in certain autoimmune conditions. In terms of treatment, the approach depends on the specific type of Bartonella infection and the severity of the symptoms. For milder infections like Cat Scratch Disease, which is often caused by Bartonella henselae, treatment may not be necessary as the condition frequently resolves on its own. However, in more severe cases or in immunocompromised individuals, antibiotics such as azithromycin or doxycycline are typically prescribed. For infections like trench fever (caused by Bartonella quintana) or bacillary angiomatosis (often seen in patients with HIV/AIDS), a more aggressive antibiotic treatment is usually required. The choice and duration of antibiotic therapy are determined based on the specific Bartonella species, the severity of the disease, and the patient's overall health. It's crucial for patients to adhere to the prescribed treatment regimen and complete the entire course of antibiotics to ensure the effective eradication of the infection and to prevent potential complications. As always, any treatment plan should be guided by a healthcare professional who can take into account the patient's individual circumstances and monitor their response to the therapy.

Bartonellosis, a group of infectious diseases caused by bacteria of the Bartonella genus, can be diagnosed using serological panels that include the Bartonella genus (IgM) marker test. This test is designed to detect Immunoglobulin M (IgM) antibodies in the blood, which are produced by the immune system as an early response to a Bartonella infection. Bartonella species, including Bartonella henselae and Bartonella quintana, are known to cause diseases such as cat scratch disease, trench fever, and bacillary angiomatosis.

The presence of IgM antibodies specific to Bartonella indicates a recent or acute infection, as these antibodies are typically produced within a week or two of infection and can persist for several months. The test employs an indirect immunofluorescence assay (IFA) or enzyme-linked immunosorbent assay (ELISA) methodology, where a patient's serum is exposed to antigens derived from Bartonella species. If specific IgM antibodies are present, they bind to these antigens, and this binding can be visualized and quantified through secondary antibodies labeled with a detectable marker. However, the interpretation of this test must be approached with caution. Cross-reactivity with antibodies produced against other pathogens, the persistence of IgM antibodies even after the resolution of infection, and the potential for false positives, particularly in populations with endemic exposure to Bartonella, can complicate the clinical picture.

Therefore, the results of the Bartonella genus (IgM) test should be considered alongside clinical symptoms, patient history, and possibly other diagnostic methods, such as PCR or culture, to accurately diagnose bartonellosis. This test is a valuable tool in the early diagnosis of Bartonella infections, but its results require careful interpretation in the broader context of the patient's clinical presentation.

Bartonella genus (IgM)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Bartonella genus (IgM) — 10,000+ markers explained
One Bartonella genus (IgM) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro